American Century Companies Portfolio holdings
American Century Companies, Inc., founded in 1958 by James E. Stowers Jr. as Twentieth Century Mutual Funds and headquartered in Kansas City, Missouri, is a privately held investment management firm renowned for its focus on delivering investment results to clients while supporting medical research. Starting with just $100,000 from 24 shareholders, it rebranded to American Century Investments in 1997 and now manages hundreds of billions in assets across mutual funds, ETFs, and institutional portfolios, emphasizing no-load funds and a client-centric approach. The firm’s unique ownership structure sees over 40% of its profits funneled to the Stowers Institute for Medical Research, which it majority-owns, funding groundbreaking biomedical research, while Nomura Holdings holds a significant minority stake. With a global presence in cities like New York, London, and Hong Kong, and a workforce of around 1,400, American Century blends financial expertise with a mission to improve lives through both wealth creation and scientific advancement.
Top Buys
| 1 |
Interactive Brokers
IBKR
|
+$222M |
| 2 |
Martin Marietta Materials
MLM
|
+$168M |
| 3 |
Fiserv
FI
|
+$123M |
| 4 |
VICI Properties
VICI
|
+$121M |
| 5 |
Reinsurance Group of America
RGA
|
+$120M |
Top Sells
| 1 |
Apple
AAPL
|
+$522M |
| 2 |
NVIDIA
NVDA
|
+$496M |
| 3 |
Microsoft
MSFT
|
+$317M |
| 4 |
Eli Lilly
LLY
|
+$273M |
| 5 |
BECN
Beacon Roofing Supply, Inc.
BECN
|
+$231M |
Sector Composition
| 1 | Technology | 24.77% |
| 2 | Financials | 15.07% |
| 3 | Consumer Discretionary | 11.87% |
| 4 | Healthcare | 10.87% |
| 5 | Industrials | 9.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CANG
2801
Cango
CANG
$817M
| $38.8K | ﹤0.01% |
10,241
+32
| +0.3% | +$121 |
|
|
VIGL
2802
DELISTED
Vigil Neuroscience
VIGL
| $36.1K | ﹤0.01% |
20,258
+288
| +1% | +$513 |
|
2803
Acrivon Therapeutics
ACRV
$47.5M
| $35.3K | ﹤0.01% |
17,381
-207
| -1% | -$420 |
|
2804
Vuzix
VUZI
$173M
| $35.2K | ﹤0.01% |
+17,254
| New | +$35.2K |
|
2805
AirSculpt Technologies
AIRS
$388M
| $31.8K | ﹤0.01% |
+13,601
| New | +$31.8K |
|
2806
Rapid Micro Biosystems
RPID
$137M
| $30.6K | ﹤0.01% |
+11,581
| New | +$30.6K |
|
2807
Pyxis Oncology
PYXS
$115M
| $25.8K | ﹤0.01% |
26,353
-273,584
| -91% | -$268K |
|
2808
HilleVax
HLVX
$105M
| $25K | ﹤0.01% |
17,220
+30
| +0.2% | +$44 |
|
2809
Prime Medicine
PRME
$743M
| $22.7K | ﹤0.01% |
11,426
| – | – |
|
2810
Applied Optoelectronics
AAOI
$1.74B
| – | – |
-100,852
| Closed | -$3.72M |
|
2811
Acumen Pharmaceuticals
ABOS
$81.2M
| – | – |
-54,278
| Closed | -$93.4K |
|
2812
Aldeyra Therapeutics
ALDX
$324M
| – | – |
-39,198
| Closed | -$196K |
|
2813
Alector
ALEC
$279M
| – | – |
-56,735
| Closed | -$107K |
|
2814
Allogene Therapeutics
ALLO
$257M
| – | – |
-232,356
| Closed | -$495K |
|
2815
Amprius Technologies
AMPX
$1.04B
| – | – |
-24,207
| Closed | -$67.8K |
|
2816
American Superconductor
AMSC
$2.54B
| – | – |
-13,008
| Closed | -$320K |
|
2817
Arvinas
ARVN
$575M
| – | – |
-252,685
| Closed | -$4.84M |
|
2818
Aspen Aerogels
ASPN
$549M
| – | – |
-1,003,184
| Closed | -$11.9M |
|
2819
AeroVironment
AVAV
$12.3B
| – | – |
-1,815
| Closed | -$279K |
|
2820
BARK
BARK
$150M
| – | – |
-26,398
| Closed | -$48.6K |
|
2821
Blink Charging
BLNK
$159M
| – | – |
-130,783
| Closed | -$182K |
|
2822
Brown & Brown
BRO
$30.8B
| – | – |
-4,469
| Closed | -$456K |
|
2823
Codexis
CDXS
$221M
| – | – |
-107,983
| Closed | -$515K |
|
2824
Celanese
CE
$5.02B
| – | – |
-10,568
| Closed | -$731K |
|
2825
Chegg
CHGG
$178M
| – | – |
-129,938
| Closed | -$209K |
|